Welcome to Dividend.com
Please help us personalize your experience.
Select the one that best describes you
abbvie logo in blue

News

Analyst Moves: Abbvie, Cardinal Health, Avon Products, More (ABBV, CAH, AVP)

Mike Deane Feb 02, 2015

Before Monday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.

Morgan Stanley Downgrades Cardinal Health

Cardinal Health (CAH ) was downgraded to “Equal-weight” at Morgan Stanley, due to a valuation call and price target of $86. Morgan Stanley’s $86 price target on CAH, suggests a 3% upside to the stock’s current price. CAH has dividend yield of 1.65%.

Keybanc Downgrades Crane

Crane Co. (CR ) was downgraded to “Hold” from “Buy” at Keybanc, based on a valuation call. Crane has a dividend yield of 2.17%.

Jefferies Downgrades Nabors Industries

Nabors Industries (NBR ) was downgraded to “Underperform” from “Hold” at Jefferies, due to lower oil prices. Jefferies has a price target of $8 on NBR, suggesting a 30% downside to the stock’s current price. NBR has a yield of 1.39%.

Telsey Downgrades Staples

Staples (SPLS ) was downgraded to “Underperform” from “Market Perform” at Telsey Advisory, based on a valuation call, as the analyst firm believes Staples’ stock price already factors in activist action. Telsey has an $18 price target on Staples, suggesting the stock will rise 6% from its current price. SPLS has a yield of 2.82%,

Deutsche Bank Downgrades Wyndham Worldwide

Wyndham Worldwide (WYN ) was downgraded to “Sell” from “Hold” at Deutsche Bank, due to WYN’s multiple negative catalysts. DB has a price target of $69 on WYN, suggesting an 18% downside to the stock’s current price. WYN has a yield of 1.67%.

Morgan Stanley Cuts Numbers on AbbVie

AbbVie Inc. (ABBV ) had its price target and estimates cut as Morgan Stanley, as the company is seeing lower sales for its hepatitis-C vaccine. MS now has a price target of $65 on ABBV, suggesting an 8% upside. ABBV has a yield of 3.25%.

Credit Suisse Lowers Numbers on Avon Products

Avon Products (AVP ) had its price target and estimates lowered at Credit Suisse, due to the company’s lower sales expectations. Credit Suisse now has a $9 price target on AVP, suggesting a 16% upside to the stock’s price. AVP has a yield of 3.1%.

Popular Articles